47045-KGZ-C-UNDP-1 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>HIV/TB - Kyrgyzstan (01-Jul-2016-30-Jun-2018)</narrative> Kyrgyzstan, TB/HIV, United Nations Development Programme Goal: To reduce TB and HIV burden in Kyrgyzstan through ensuring universal access to timely and quality TB diagnosis and treatment, implementing evidence based HIV preventive activities focused primarily on key affected populations, providing treatment, care and support to PLHIV, creating enabling environment and ensuring programs sustainability. Objectives: To create enabling environment and ensure programs sustainability; To ensure universal access to timely and quality diagnosis and treatment of all forms of TB including M/XDR-TB; To implement evidence-based HIV preventive activities focused primarily on key affected populations and provide treatment, care and support to PLHIV. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division xxxx xxxx Fund Portfolio Manager +41 58 791 1700 xxxx https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Kyrgyzstan TB/HIV TB/HIV Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases 18617455.00 Global Fund commitment to KGZ-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 583251.00 Global Fund disbursement to KGZ-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 3054315.00 Global Fund disbursement to KGZ-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 1479365.09 Global Fund disbursement to KGZ-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 2657004.91 Global Fund disbursement to KGZ-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 6937211.00 Global Fund disbursement to KGZ-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 2245043.00 Global Fund disbursement to KGZ-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 1419317.00 Global Fund disbursement to KGZ-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -241948.00 Global Fund commitment to KGZ-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 3509263.00 Global Fund commitment to KGZ-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 3509263.00 Global Fund disbursement to KGZ-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 100000.00 Global Fund commitment to KGZ-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -70000.00 Global Fund commitment to KGZ-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 70000.00 Funds returned to the Global Fund from KGZ-C-UNDPP01. United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria 50000.00 Global Fund disbursement to KGZ-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 25000.00 Global Fund commitment to KGZ-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -50000.00 Global Fund commitment to KGZ-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -25000.00 Global Fund commitment to KGZ-C-UNDPP01. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>KP-other 1: Percentage of PWID prisoners reached with HIV prevention programs - defined package of services</narrative> Module: Comprehensive prevention programs for people who inject drugs (PWID) and their partners. <narrative>KP-other 1: Percentage of PWID prisoners reached with HIV prevention programs - defined package of services</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 1375; Denominator: 8000. Numerator: 1450; Denominator: 8000. Numerator: 14682; Denominator: 25000. Numerator: 1500; Denominator: 8000. Numerator: 1501; Denominator: 8433. Numerator: 1550; Denominator: 8000. Numerator: 1453; Denominator: 8522. Numerator: 1575; Denominator: 8000. Numerator: 1468; Denominator: 8772. <narrative>KP-other 1: Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results (prisoners)</narrative> Module: Comprehensive prevention programs for people who inject drugs (PWID) and their partners. <narrative>KP-other 1: Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results (prisoners)</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 4000; Denominator: 8000; Percentage: 50%. Numerator: 2420; Denominator: 8000; Percentage: 30.3%. Numerator: 2713; Denominator: 8300. Numerator: 2640; Denominator: 8000; Percentage: 33%. Numerator: 3629; Denominator: 8443; Percentage: 43%. Numerator: 2640; Denominator: 8000; Percentage: 33%. Numerator: 3359; Denominator: 8522; Percentage: 39.4%. Numerator: 2800; Denominator: 8000; Percentage: 35%. Numerator: 3501; Denominator: 8772; Percentage: 39.9%. <narrative>Number of needles and syringes distributed per person who injects drugs per year by needle and syringe programs</narrative> Module: Comprehensive prevention programs for people who inject drugs (PWID) and their partners. <narrative>Number of needles and syringes distributed per person who injects drugs per year by needle and syringe programs</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 293. Numerator: 110. Numerator: 3760078; Denominator: 25000; Percentage: 150.4%. Numerator: 240. Numerator: 219.91. <narrative>Percentage of individuals receiving Opioid Substitution Therapy who received treatment for at least 6 months</narrative> Module: Comprehensive prevention programs for people who inject drugs (PWID) and their partners. <narrative>Percentage of individuals receiving Opioid Substitution Therapy who received treatment for at least 6 months</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 174; Denominator: 359. Numerator: 247; Denominator: 380. Numerator: 123; Denominator: 241. Numerator: 272; Denominator: 400. Numerator: 120; Denominator: 254. Numerator: 294; Denominator: 420. Numerator: 123; Denominator: 262. Numerator: 315; Denominator: 450. Numerator: 126; Denominator: 253. <narrative>Percentage of people who inject drugs reached with HIV prevention programs - defined package of services</narrative> Module: Comprehensive prevention programs for people who inject drugs (PWID) and their partners. <narrative>Percentage of people who inject drugs reached with HIV prevention programs - defined package of services</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 11405; Denominator: 25000. Numerator: 13750; Denominator: 25000. Numerator: 14682; Denominator: 25000. Numerator: 14375; Denominator: 25000. Numerator: 15859; Denominator: 25000. Numerator: 15000; Denominator: 25000. Numerator: 16430; Denominator: 25000. Numerator: 15625; Denominator: 25000. Numerator: 15828; Denominator: 25000. <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative> Module: Comprehensive prevention programs for people who inject drugs (PWID) and their partners. <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 4061; Denominator: 25000. Numerator: 5912; Denominator: 25000. Numerator: 6950; Denominator: 25000. Numerator: 6600; Denominator: 25000. Numerator: 7503; Denominator: 25000. Numerator: 6600; Denominator: 25000. Numerator: 7628; Denominator: 25000. Numerator: 7312; Denominator: 25000. Numerator: 8332; Denominator: 25000. <narrative>Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative> Module: Comprehensive prevention programs for sex workers and their clients. <narrative>Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 3813; Denominator: 7103. Numerator: 4260; Denominator: 7103. Numerator: 4050; Denominator: 7103. Numerator: 4430; Denominator: 7103. Numerator: 3790; Denominator: 7103. Numerator: 4615; Denominator: 7103. Numerator: 3932; Denominator: 7103. Numerator: 4793; Denominator: 7103. Numerator: 3792; Denominator: 7103. <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative> Module: Comprehensive prevention programs for sex workers and their clients. <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 898; Denominator: 7103. Numerator: 1630; Denominator: 7103. Numerator: 1097; Denominator: 7103. Numerator: 2030; Denominator: 7103. Numerator: 1350; Denominator: 7103. Numerator: 2030; Denominator: 7103. Numerator: 1679; Denominator: 7103. Numerator: 2236; Denominator: 7103. Numerator: 2134; Denominator: 7103. <narrative>MDR TB-other 2: Number of MDR/XDR/RR-TB patients on treatment receiving patient support (food, hygiene packages, money allowances) for better adherence to treatment- includes inpatient and outpatient treatment</narrative> Module: MDR-TB. <narrative>MDR TB-other 2: Number of MDR/XDR/RR-TB patients on treatment receiving patient support (food, hygiene packages, money allowances) for better adherence to treatment- includes inpatient and outpatient treatment</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 1227. Numerator: 1939. Numerator: 1476. Numerator: 2254. Numerator: 1689. Numerator: 2413. Numerator: 1684; Percentage: 70%. Numerator: 2413. <narrative>MDR TB-other 3: Percentage and number of patients with symptoms or signs suggestive for TB examined by Xpert MTB/RIF methodology and confirmed with active TB</narrative> Module: MDR-TB. <narrative>MDR TB-other 3: Percentage and number of patients with symptoms or signs suggestive for TB examined by Xpert MTB/RIF methodology and confirmed with active TB</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 2174; Denominator: 6699. Numerator: 760; Denominator: 9500. Numerator: 1325; Denominator: 6854. Numerator: 1520; Denominator: 19000. Numerator: 2440; Denominator: 13121. Numerator: 1205; Denominator: 7295. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Module: MDR-TB. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Geographic coverage: National. Aggregation: Non cumulative - other. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Module: MDR-TB. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 1157. Numerator: 795. Numerator: 601; Denominator: 795; Percentage: 75.6%. Numerator: 663. Numerator: 702. Numerator: 662. Numerator: 686. Numerator: 712. Numerator: 598. <narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative> Module: MDR-TB. <narrative>Percentage of previously treated TB patients receiving DST (bacteriologically positive cases only)</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 701; Denominator: 935. Numerator: 419; Denominator: 435. Numerator: 469; Denominator: 493. Numerator: 919; Denominator: 1286. Numerator: 537; Denominator: 720. <narrative>Percentage of HIV-positive pregnant women who received antiretrovirals to reduce the risk of mother-to-child transmission</narrative> Module: PMTCT. <narrative>Percentage of HIV-positive pregnant women who received antiretrovirals to reduce the risk of mother-to-child transmission</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 142; Denominator: 160. Numerator: 123; Denominator: 117. Numerator: 120; Denominator: 160. <narrative>Percentage of infants born to HIV-positive women receiving a virological test for HIV within 2 months of birth</narrative> Module: PMTCT. <narrative>Percentage of infants born to HIV-positive women receiving a virological test for HIV within 2 months of birth</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 75; Denominator: 101. Numerator: 84; Denominator: 117. Numerator: 113; Denominator: 126. <narrative>Percentage of MSM reached with HIV prevention programs - defined package of services</narrative> Module: Prevention programs for MSM and TGs. <narrative>Percentage of MSM reached with HIV prevention programs - defined package of services</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 1717; Denominator: 11692. Numerator: 3270; Denominator: 11692. Numerator: 3765; Denominator: 11692. Numerator: 3815; Denominator: 11692. Numerator: 5344; Denominator: 11692. Numerator: 4360; Denominator: 11692. Numerator: 5754; Denominator: 11692. Numerator: 5387; Denominator: 11692. Numerator: 7205; Denominator: 11692. <narrative>Percentage of MSM that have received an HIV test during the reporting period and know their results</narrative> Module: Prevention programs for MSM and TGs. <narrative>Percentage of MSM that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. Numerator: 399; Denominator: 11692. Numerator: 1727; Denominator: 11692. Numerator: 1841; Denominator: 11692. Numerator: 2158; Denominator: 11692. Numerator: 2237; Denominator: 11692. Numerator: 2158; Denominator: 11692. Numerator: 2659; Denominator: 11692. Numerator: 3207; Denominator: 11692. Numerator: 3358; Denominator: 11692. <narrative>RLB-other 1: Number of documented key affected population human rights violations (desegregated by KAP groups)</narrative> Module: Removing legal barriers to access. <narrative>RLB-other 1: Number of documented key affected population human rights violations (desegregated by KAP groups)</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative. <narrative>Percentage of HIV-positive patients who were screened for TB in HIV care or treatment settings</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive patients who were screened for TB in HIV care or treatment settings</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 2242; Denominator: 2585. Numerator: 2735; Denominator: 2861. Numerator: 3251; Denominator: 3370. Numerator: 3464; Denominator: 3578. <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 110; Denominator: 203. Numerator: 53; Denominator: 56. Numerator: 87; Denominator: 93. Numerator: 70; Denominator: 75. <narrative>Percentage of new HIV-positive patients starting IPT during the reporting period</narrative> Module: TB/HIV. <narrative>Percentage of new HIV-positive patients starting IPT during the reporting period</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 70; Denominator: 612. Numerator: 135; Denominator: 219. Numerator: 231; Denominator: 277. Numerator: 241; Denominator: 280. <narrative>Percentage of adults and children that initiated ART, with an undetectable viral load at 12 months (<1000 copies/ml)</narrative> Module: Treatment, care and support. <narrative>Percentage of adults and children that initiated ART, with an undetectable viral load at 12 months (<1000 copies/ml)</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 1350. Numerator: 1644; Denominator: 2668; Percentage: 61.6%. <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative> Module: Treatment, care and support. <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 1900; Denominator: 9410; Percentage: 20.2%. Numerator: 385; Denominator: 9300; Percentage: 4.14%. Numerator: 2700; Denominator: 9300; Percentage: 29%. Numerator: 2668; Denominator: 8100; Percentage: 32.9%. Numerator: 3100; Denominator: 9300; Percentage: 33.3%. Numerator: 2995; Denominator: 8500; Percentage: 35.2%. Numerator: 3478; Denominator: 9300; Percentage: 37.4%. Numerator: 3237; Denominator: 8500; Percentage: 38.1%. Numerator: 445. Numerator: 3926; Denominator: 8500; Percentage: 46.2%. Numerator: 3454; Denominator: 7600; Percentage: 45.4%. <narrative>TCS-other 1: Number of PLHIV reached with community care and support programme</narrative> Module: Treatment, care and support. <narrative>TCS-other 1: Number of PLHIV reached with community care and support programme</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 1383; Denominator: 2585. Numerator: 1410; Denominator: 2694. Numerator: 2514; Denominator: 2861. Numerator: 1480; Denominator: 2694. Numerator: 2851; Denominator: 3128. Numerator: 1616; Denominator: 2694. Numerator: 3117; Denominator: 3370. Numerator: 2032; Denominator: 3128. Numerator: 3029; Denominator: 3578. 47045-KGZ-C-UNDP-2 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Effective HIV and TB control project in Kyrgyzstan - Kyrgyzstan (01-Jul-2018-31-Dec-2020)</narrative> Kyrgyzstan, TB/HIV, United Nations Development Programme Goals: To minimize the impact of the HIV epidemic by reducing 50% of the incidence and mortality by 2021 compared to 2015, as a stage towards eliminating the epidemic in the Kyrgyz Republic by 2030; Success of treatment among sensitive forms of TB is achieved 85%, among drug resistant forms of MDR-TB by 2020, 67% according to NTP-5. Objectives: Reduce the number of new HIV infections, especially among key populations by 50% by 2021 compared to 2015; Ensure that 90% of people living with HIV (PLHIV) are aware of their HIV status; Cover 90% of people living with HIV with antiretroviral therapy (ART) and achieve viral load suppression in 90% of people receiving ART by 2021; Achieve a reduction to less than 2% of mother-to-child transmission of HIV, which will lead to its elimination by 2021; To reduce the level of stigma and discrimination to zero in government organizations providing HIV-related services to key populations and PLHIV; Reduce to zero the number of laws, other regulations and practices that discriminate against people living with HIV and key populations; Ensure coordination and sustainable financing of HIV response measures by gradually increasing the share of government funding for HIV prevention and treatment programs to 50% by 2021; To ensure universal access to timely and quality diagnosis and treatment of all forms of TB including M/XDR-TB. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division xxxx xxxx Fund Portfolio Manager +41 58 791 1700 xxxx https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Kyrgyzstan Tuberculosis HIV Multicomponent, RSSH Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage HIV -> Comprehensive prevention programs for MSM -> Behavioral interventions for MSM HIV -> Comprehensive prevention programs for MSM -> Condoms and lubricant programming for MSM HIV -> Comprehensive prevention programs for MSM -> HIV testing services for MSM HIV -> Comprehensive prevention programs for people who inject drugs (PWID) and their partners -> Condoms and lubricant programming for PWID HIV -> Comprehensive prevention programs for people who inject drugs (PWID) and their partners -> HIV testing services for PWID HIV -> Comprehensive prevention programs for people who inject drugs (PWID) and their partners -> Needle and Syringe programs for PWID and their partners HIV -> Comprehensive prevention programs for people who inject drugs (PWID) and their partners -> OST and other drug dependence treatment for PWID HIV -> Comprehensive prevention programs for people who inject drugs (PWID) and their partners -> Overdose prevention and management HIV -> Comprehensive prevention programs for sex workers and their clients -> Behavioral interventions for sex workers HIV -> Comprehensive prevention programs for sex workers and their clients -> Condoms and lubricant programming for sex workers HIV -> Comprehensive prevention programs for sex workers and their clients -> HIV testing services for sex workers HIV -> Comprehensive programs for people in prisons and other closed settings -> Behavioral interventions for people in prisons and other closed settings HIV -> Comprehensive programs for people in prisons and other closed settings -> HIV testing services for people in prisons and other closed settings HIV -> PMTCT -> Prong 3: Preventing vertical HIV transmission HIV -> PMTCT -> Prong 4: Treatment, care and support to mothers living with HIV, their children and families HIV -> Prevention programs for other vulnerable populations -> HIV testing services for other vulnerable populations HIV -> Reducing human rights-related barriers to HIV/TB services -> HIV and HIV/TB-related legal services HIV -> Treatment, care and support -> Counseling and psycho-social support HIV -> Treatment, care and support -> Differentiated ART service delivery HIV -> Treatment, care and support -> Treatment adherence HIV -> Treatment, care and support -> Treatment monitoring - Viral load Multicomponent -> Program management -> Grant management RSSH -> RSSH: Community systems strengthening -> Institutional capacity building, planning and leadership development RSSH -> RSSH: Health management information systems and M&E -> Routine reporting Tuberculosis -> MDR-TB -> Case detection and diagnosis (MDR-TB) Tuberculosis -> MDR-TB -> Community MDR-TB care delivery Tuberculosis -> MDR-TB -> Treatment (MDR-TB) Tuberculosis -> TB/HIV -> TB/HIV - Collaborative interventions 3229329.58 8710212.69 14080313.19 12361316.41 Global Fund commitment to KGZ-C-UNDPP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 8201386.00 Global Fund disbursement to KGZ-C-UNDPP02 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 1081903.00 Global Fund disbursement to KGZ-C-UNDPP02 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 1043454.00 Global Fund disbursement to KGZ-C-UNDPP02 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 25000.00 Global Fund commitment to KGZ-C-UNDPP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 2034573.41 Global Fund disbursement to KGZ-C-UNDPP02 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -25000.00 Global Fund commitment to KGZ-C-UNDPP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 50000.00 Global Fund commitment to KGZ-C-UNDPP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 3960276.59 Global Fund commitment to KGZ-C-UNDPP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 1769345.59 Global Fund disbursement to KGZ-C-UNDPP02 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 959364.00 Global Fund disbursement to KGZ-C-UNDPP02 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 50000.00 Global Fund disbursement to KGZ-C-UNDPP02 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 845595.00 Global Fund disbursement to KGZ-C-UNDPP02 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 385972.00 Global Fund disbursement to KGZ-C-UNDPP02 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 6015055.00 Global Fund commitment to KGZ-C-UNDPP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 50000.00 Global Fund commitment to KGZ-C-UNDPP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 5500000.00 Global Fund disbursement to KGZ-C-UNDPP02 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 515055.00 Global Fund disbursement to KGZ-C-UNDPP02 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 933375.61 Global Fund commitment to KGZ-C-UNDPP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 933375.61 Global Fund disbursement to KGZ-C-UNDPP02 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 50000.00 Global Fund disbursement to KGZ-C-UNDPP02 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 8094.83 Funds returned to the Global Fund from KGZ-C-UNDPP02 (Multilateral). United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria -8094.83 Global Fund commitment to KGZ-C-UNDPP02. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 3229330.00 Expenditure reported by United Nations Development Programme for KGZ-C-UNDPP02, Jul 2018 to Dec 2018. United Nations Development Programme 8710213.00 Expenditure reported by United Nations Development Programme for KGZ-C-UNDPP02, Jan 2019 to Dec 2019. United Nations Development Programme 13077000.72 Expenditure reported by United Nations Development Programme for KGZ-C-UNDPP02, Jan 2020 to Dec 2020. United Nations Development Programme 746151.51 Expenditure reported by United Nations Development Programme for KGZ-C-UNDPP02, Jan 2021 to Jun 2021. United Nations Development Programme <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>Percentage of men who have sex with men reached with HIV prevention programs - defined package of services</narrative> Module: Comprehensive prevention programs for MSM. <narrative>Percentage of men who have sex with men reached with HIV prevention programs - defined package of services</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative - other. Numerator: 3765; Denominator: 11692. Numerator: 6700; Denominator: 11692. Numerator: 8503; Denominator: 11692. Numerator: 7980; Denominator: 11692. Numerator: 9606; Denominator: 11692. Numerator: 9260; Denominator: 11692. Numerator: 9565; Denominator: 11692. Numerator: 10100; Denominator: 11692. Numerator: 10039; Denominator: 11692. Numerator: 10940; Denominator: 11692. Numerator: 11044; Denominator: 11692. <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative> Module: Comprehensive prevention programs for MSM. <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: Subnational. Aggregation: Non cumulative - special. Numerator: 1841; Denominator: 11692. Numerator: 2793; Denominator: 11692. Numerator: 3419; Denominator: 11692. Numerator: 4165; Denominator: 11692. Numerator: 4420; Denominator: 11692. Numerator: 4165; Denominator: 11692. Numerator: 3972; Denominator: 11692. Numerator: 4920; Denominator: 11692. Numerator: 3125; Denominator: 11692. Numerator: 4920; Denominator: 11692. Numerator: 4764; Denominator: 11692. <narrative>Percentage of individuals receiving Opioid Substitution Therapy who received treatment for at least 6 months</narrative> Module: Comprehensive prevention programs for people who inject drugs (PWID) and their partners. <narrative>Percentage of individuals receiving Opioid Substitution Therapy who received treatment for at least 6 months</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 123; Denominator: 241. Numerator: 150; Denominator: 250. Numerator: 77; Denominator: 140. Numerator: 160; Denominator: 255. Numerator: 56; Denominator: 99. Numerator: 169; Denominator: 260. Numerator: 58; Denominator: 107. Numerator: 178; Denominator: 265. Numerator: 55; Denominator: 98. Numerator: 189; Denominator: 270. Numerator: 51; Denominator: 81. <narrative>Percentage of people who inject drugs reached with HIV prevention programs - defined package of services</narrative> Module: Comprehensive prevention programs for people who inject drugs (PWID) and their partners. <narrative>Percentage of people who inject drugs reached with HIV prevention programs - defined package of services</narrative> Geographic coverage: National. Aggregation: Non cumulative - other. Numerator: 14682; Denominator: 25000. Numerator: 16250; Denominator: 25000. Numerator: 16530; Denominator: 25000. Numerator: 16875; Denominator: 25000. Numerator: 15835; Denominator: 25000. Numerator: 17500; Denominator: 25000. Numerator: 16195; Denominator: 25000. Numerator: 18125; Denominator: 25000. Numerator: 16328; Denominator: 25000. Numerator: 18750; Denominator: 25000. Numerator: 16636; Denominator: 25000. <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative> Module: Comprehensive prevention programs for people who inject drugs (PWID) and their partners. <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: National. Aggregation: Non cumulative - special. Numerator: 6950; Denominator: 25000. Numerator: 7313; Denominator: 25000. Numerator: 8576; Denominator: 25000. Numerator: 7875; Denominator: 25000. Numerator: 8464; Denominator: 25000. Numerator: 7875; Denominator: 25000. Numerator: 8171; Denominator: 25000. Numerator: 8437; Denominator: 25000. Numerator: 6106; Denominator: 25000. Numerator: 8438; Denominator: 25000. Numerator: 9608; Denominator: 25000. <narrative>Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative> Module: Comprehensive prevention programs for sex workers and their clients. <narrative>Percentage of sex workers reached with HIV prevention programs - defined package of services</narrative> Geographic coverage: National. Aggregation: Non cumulative - other. Numerator: 4050; Denominator: 7103. Numerator: 4970; Denominator: 7103. Numerator: 4359; Denominator: 7103. Numerator: 5148; Denominator: 7103. Numerator: 3604; Denominator: 7103. Numerator: 5325; Denominator: 7103. Numerator: 3782; Denominator: 7103. Numerator: 5503; Denominator: 7103. Numerator: 3481; Denominator: 7103. Numerator: 5680; Denominator: 7103. Numerator: 3470; Denominator: 7103. <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative> Module: Comprehensive prevention programs for sex workers and their clients. <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 1097; Denominator: 7103. Numerator: 2237; Denominator: 7103. Numerator: 2218; Denominator: 7103. Numerator: 2395; Denominator: 7103. Numerator: 1966; Denominator: 7103. Numerator: 2395; Denominator: 7103. Numerator: 1433; Denominator: 7130. Numerator: 2555; Denominator: 7103. Numerator: 1588; Denominator: 7103. Numerator: 2555; Denominator: 7103. Numerator: 1328; Denominator: 7103. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Module: MDR-TB. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Geographic coverage: National. Aggregation: Non cumulative. <narrative>Number of cases of XDR TB enrolled on treatment</narrative> Module: MDR-TB. <narrative>Number of cases of XDR TB enrolled on treatment</narrative> Geographic coverage: National. Aggregation: Non cumulative. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Module: MDR-TB. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 1216. Numerator: 1249. Numerator: 1249. Numerator: 1249. Numerator: 1249. Numerator: 1249. Numerator: 34. Numerator: 34. Numerator: 34. Numerator: 34. Numerator: 34. Numerator: 463. Numerator: 463. Numerator: 463. Numerator: 463. Numerator: 463. Numerator: 820. Numerator: 820. Numerator: 820. Numerator: 820. Numerator: 820. Numerator: 700. Numerator: 671. Numerator: 659; Denominator: 671; Percentage: 98.2%. Numerator: 12; Denominator: 671; Percentage: 1.8%. Numerator: 248; Denominator: 671; Percentage: 37%. Numerator: 423; Denominator: 671; Percentage: 63%. Numerator: 720. Numerator: 674. Numerator: 662; Denominator: 674; Percentage: 98.2%. Numerator: 12; Denominator: 674; Percentage: 1.8%. Numerator: 245; Denominator: 674; Percentage: 36.4%. Numerator: 429; Denominator: 674; Percentage: 63.6%. Numerator: 720. Numerator: 665. Numerator: 645. Numerator: 20. Numerator: 247. Numerator: 418. Numerator: 740. Numerator: 606. Numerator: 587; Denominator: 606; Percentage: 96.9%. Numerator: 19; Denominator: 606; Percentage: 3.1%. Numerator: 231; Denominator: 606; Percentage: 38.1%. Numerator: 375; Denominator: 606; Percentage: 61.9%. Numerator: 740. Numerator: 327. Numerator: 321; Denominator: 327; Percentage: 98.2%. Numerator: 6; Denominator: 327; Percentage: 1.8%. Numerator: 144; Denominator: 327; Percentage: 44%. Numerator: 183; Denominator: 327; Percentage: 56%. <narrative>Percentage of confirmed MDR-TB cases tested for susceptibility to any fluoroquinolone and any second-line injectable drug</narrative> Module: MDR-TB. <narrative>Percentage of confirmed MDR-TB cases tested for susceptibility to any fluoroquinolone and any second-line injectable drug</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 415; Denominator: 930. Numerator: 440; Denominator: 847. Numerator: 464; Denominator: 709. Numerator: 485; Denominator: 731. Numerator: 505; Denominator: 733. Numerator: 289; Denominator: 369. <narrative>Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative> Module: PMTCT. <narrative>Percentage of HIV-positive women who received ART during pregnancy and/or labour and delivery</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 123; Denominator: 127. Numerator: 128; Denominator: 129. Numerator: 121; Denominator: 127. Numerator: 155; Denominator: 162. <narrative>Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results</narrative> Module: Prevention programs for other vulnerable populations. <narrative>Percentage of other vulnerable populations that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: National. Aggregation: Non cumulative - special. Numerator: 2713; Denominator: 8300. Numerator: 2800; Denominator: 8300. Numerator: 2865; Denominator: 8690. Numerator: 2975; Denominator: 8300. Numerator: 2404; Denominator: 7592. Numerator: 2975; Denominator: 8300. Numerator: 2892; Denominator: 7079. Numerator: 3400; Denominator: 8300. Numerator: 2902; Denominator: 7024. Numerator: 3400; Denominator: 8300. Numerator: 2878; Denominator: 6752. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Module: TB care and prevention. <narrative>Number of notified cases of all forms of TB (i.e. bacteriologically confirmed + clinically diagnosed), new and relapse cases</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 7026. Numerator: 6619. Numerator: 6619. Numerator: 6619. Numerator: 6619. Numerator: 6619. Numerator: 407. Numerator: 407. Numerator: 407. Numerator: 407. Numerator: 407. Numerator: 3449. Numerator: 3449. Numerator: 3449. Numerator: 3449. Numerator: 3449. Numerator: 2993. Numerator: 2993. Numerator: 2993. Numerator: 2993. Numerator: 2993. Numerator: 4033. Numerator: 4033. Numerator: 4033. Numerator: 4033. Numerator: 4033. Numerator: 6870. Numerator: 6870. Numerator: 6870. Numerator: 6870. Numerator: 6870. Numerator: 915. Numerator: 915. Numerator: 915. Numerator: 915. Numerator: 915. Numerator: 210. Numerator: 210. Numerator: 210. Numerator: 210. Numerator: 210. Numerator: 3500. Numerator: 3191. Numerator: 3040; Denominator: 3191; Percentage: 95.3%. Numerator: 151; Denominator: 3191; Percentage: 4.7%. Numerator: 1735; Denominator: 3191; Percentage: 54.4%. Numerator: 1338; Denominator: 3191; Percentage: 41.9%. Numerator: 1853; Denominator: 3191; Percentage: 58.1%. Numerator: 2861; Denominator: 3191; Percentage: 89.7%. Numerator: 235; Denominator: 3191; Percentage: 7.4%. Numerator: 95; Denominator: 3191; Percentage: 3%. Numerator: 3475. Numerator: 3023. Numerator: 2873; Denominator: 3023; Percentage: 95%. Numerator: 150; Denominator: 3023; Percentage: 5%. Numerator: 1632; Denominator: 3023; Percentage: 54%. Numerator: 1218; Denominator: 3023; Percentage: 40.3%. Numerator: 1805; Denominator: 3023; Percentage: 59.7%. Numerator: 2715; Denominator: 3023; Percentage: 89.8%. Numerator: 237; Denominator: 3023; Percentage: 7.8%. Numerator: 71; Denominator: 3023; Percentage: 2.4%. Numerator: 3450. Numerator: 3241. Numerator: 3075. Numerator: 166. Numerator: 1895. Numerator: 1420. Numerator: 1821. Numerator: 3005. Numerator: 176. Numerator: 60. Numerator: 3425. Numerator: 2965. Numerator: 2723; Denominator: 2965; Percentage: 91.8%. Numerator: 242; Denominator: 2965; Percentage: 8.2%. Numerator: 1748; Denominator: 2965; Percentage: 59%. Numerator: 1194; Denominator: 2965; Percentage: 40.3%. Numerator: 1771; Denominator: 2965; Percentage: 59.7%. Numerator: 2710; Denominator: 2965; Percentage: 91.4%. Numerator: 176; Denominator: 2965; Percentage: 5.9%. Numerator: 79; Denominator: 2965; Percentage: 2.7%. Numerator: 3400. Numerator: 1743. Numerator: 1683; Denominator: 1743; Percentage: 96.6%. Numerator: 60; Denominator: 1743; Percentage: 3.4%. Numerator: 1042; Denominator: 1743; Percentage: 59.8%. Numerator: 771; Denominator: 1743; Percentage: 44.2%. Numerator: 972; Denominator: 1743; Percentage: 55.8%. Numerator: 1592; Denominator: 1743; Percentage: 91.3%. Numerator: 97; Denominator: 1743; Percentage: 5.6%. Numerator: 54; Denominator: 1743; Percentage: 3.1%. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 144; Denominator: 210. Numerator: 75; Denominator: 81. Numerator: 66; Denominator: 72. Numerator: 55; Denominator: 58. Numerator: 75; Denominator: 77. Numerator: 44; Denominator: 44. <narrative>Percentage of people living with HIV initiated on ART who are screened for TB in HIV treatment settings</narrative> Module: TB/HIV. <narrative>Percentage of people living with HIV initiated on ART who are screened for TB in HIV treatment settings</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 2735; Denominator: 2861. Numerator: 3539; Denominator: 4033. Numerator: 3626; Denominator: 3764. Numerator: 3888; Denominator: 4031. Numerator: 4007; Denominator: 4113. Numerator: 4196; Denominator: 4290. <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative> Module: TB/HIV. <narrative>Percentage of registered new and relapse TB patients with documented HIV status</narrative> Geographic coverage: National. Aggregation: Non cumulative. Numerator: 2956; Denominator: 3191. Numerator: 2786; Denominator: 3023. Numerator: 3065; Denominator: 3241. Numerator: 2789; Denominator: 2965. Numerator: 1646; Denominator: 1743. <narrative>Percentage of people living with HIV and on ART, who have a suppressed viral load at 12 months (<1000 copies/ml)</narrative> Module: Treatment, care and support. <narrative>Percentage of people living with HIV and on ART, who have a suppressed viral load at 12 months (<1000 copies/ml)</narrative> Geographic coverage: National. Aggregation: Cumulative annually. Numerator: 1644; Denominator: 2668. Numerator: 2405; Denominator: 4373. Numerator: 2545; Denominator: 3718. Numerator: 3935; Denominator: 5873. Numerator: 3235; Denominator: 4058. Numerator: 5994; Denominator: 7587. Numerator: 3843; Denominator: 4435. <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative> Module: Treatment, care and support. <narrative>Percentage of people living with HIV currently receiving antiretroviral therapy</narrative> Geographic coverage: National. Aggregation: Non cumulative - other. Numerator: 2668; Denominator: 8100; Percentage: 32.94%. Numerator: 2251; Denominator: 7900; Percentage: 0.28%. Numerator: 2251; Denominator: 7900; Percentage: 0.28%. Numerator: 2251; Denominator: 7900; Percentage: 0.28%. Numerator: 2251; Denominator: 7900; Percentage: 0.28%. Numerator: 2251; Denominator: 7900; Percentage: 0.28%. Numerator: 417; Percentage: 2.08%. Numerator: 417; Percentage: 2.08%. Numerator: 417; Percentage: 2.08%. Numerator: 417; Percentage: 2.08%. Numerator: 417; Percentage: 2.08%. Numerator: 1205; Denominator: 8100; Percentage: 0.15%. Numerator: 1205; Denominator: 8100; Percentage: 0.15%. Numerator: 1205; Denominator: 8100; Percentage: 0.15%. Numerator: 1205; Denominator: 8100; Percentage: 0.15%. Numerator: 1205; Denominator: 8100; Percentage: 0.15%. Numerator: 1463; Denominator: 8100; Percentage: 0.18%. Numerator: 1463; Denominator: 8100; Percentage: 0.18%. Numerator: 1463; Denominator: 8100; Percentage: 0.18%. Numerator: 1463; Denominator: 8100; Percentage: 0.18%. Numerator: 1463; Denominator: 8100; Percentage: 0.18%. Numerator: 4373; Denominator: 8500; Percentage: 51.45%. Numerator: 3718; Denominator: 7600; Percentage: 48.9%. Numerator: 3271; Denominator: 7500; Percentage: 43.6%. Numerator: 447. Numerator: 1666; Denominator: 7600; Percentage: 21.9%. Numerator: 2052; Denominator: 7600; Percentage: 27%. Numerator: 5123; Denominator: 9276; Percentage: 55.23%. Numerator: 3762; Denominator: 8500; Percentage: 44.3%. Numerator: 3324; Denominator: 8200; Percentage: 40.5%. Numerator: 438; Denominator: 500; Percentage: 87.6%. Numerator: 1717; Denominator: 8500; Percentage: 20.2%. Numerator: 2045; Denominator: 8500; Percentage: 24.1%. Numerator: 5873; Denominator: 9276; Percentage: 63.31%. Numerator: 4058; Denominator: 8500; Percentage: 47.7%. Numerator: 3632; Denominator: 8200; Percentage: 44.3%. Numerator: 426; Denominator: 500; Percentage: 85.2%. Numerator: 1854; Denominator: 2700; Percentage: 68.7%. Numerator: 2204; Denominator: 5400; Percentage: 40.8%. Numerator: 6730; Denominator: 9371; Percentage: 71.82%. Numerator: 4328; Denominator: 10000; Percentage: 43.3%. Numerator: 3932; Denominator: 10000; Percentage: 39.3%. Numerator: 396; Denominator: 10000; Percentage: 4%. Numerator: 1963; Denominator: 10000; Percentage: 19.6%. Numerator: 2365; Denominator: 10000; Percentage: 23.6%. Numerator: 7587; Denominator: 9371; Percentage: 80.96%. Numerator: 4435; Denominator: 10000; Percentage: 44.4%. Numerator: 4115; Denominator: 9700; Percentage: 42.4%. Numerator: 320; Denominator: 500; Percentage: 64%. Numerator: 2031; Denominator: 10000; Percentage: 20.3%. Numerator: 2404; Denominator: 10000. 47045-KGZ-C-UNDP-3 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Effective HIV and TB control project in the Kyrgyz Republic - Kyrgyzstan (01-Jan-2021-31-Dec-2023)</narrative> Kyrgyzstan, TB/HIV, United Nations Development Programme Goals: To minimize the impact of the HIV epidemic by reducing 50% of the incidence and mortality by 2023 compared to 2015, as a stage towards eliminating the epidemic in the Kyrgyz Republic by 2030; Success of treatment among drug resistant forms of MDR-TB by 2023, 75% according to NTP-5. Objectives: Reduce the number of new HIV infections, especially among key populations by 70% by 2023 compared to 2015; Ensure that 90% of people living with HIV (PLHIV) are aware of their HIV status; Cover 90% of people living with HIV with antiretroviral therapy (ART) and achieve viral load suppression in 90% of people receiving ART by 2023; Achieve a reduction to less than 2% of mother-to-child transmission of HIV, which will lead to its elimination by 2021; To reduce the level of stigma and discrimination to zero in government organizations providing HIV-related services to key populations and PLHIV; Reduce to zero the number of laws, other regulations and practices that discriminate against people living with HIV and key populations; Ensure coordination and sustainable financing of HIV response measures by gradually increasing the share of government funding for HIV prevention and treatment programs to 60% by 2023; To ensure universal access to timely and quality diagnosis and treatment of all forms of TB including M/XDR-TB. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division xxxx xxxx Fund Portfolio Manager +41 58 791 1700 xxxx https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Kyrgyzstan Tuberculosis Multicomponent, RSSH HIV Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage HIV -> Differentiated HIV Testing Services -> Community-based testing HIV -> Differentiated HIV Testing Services -> Facility-based testing HIV -> Prevention -> Behavior change interventions HIV -> Prevention -> Needle and syringe programs HIV -> Prevention -> Opioid substitution therapy and other medically assisted drug dependence treatment HIV -> Reducing human rights-related barriers to HIV/TB services -> Community mobilization and advocacy (HIV/TB) HIV -> Reducing human rights-related barriers to HIV/TB services -> HIV and HIV/TB-related legal services HIV -> Reducing human rights-related barriers to HIV/TB services -> Stigma and discrimination reduction (HIV/TB) HIV -> Treatment, care and support -> Counseling and psycho-social support HIV -> Treatment, care and support -> Differentiated ART service delivery and HIV care Multicomponent -> Program management -> Grant management RSSH -> RSSH: Health management information systems and M&E -> Routine reporting RSSH -> RSSH: Laboratory systems -> Infrastructure and equipment management systems RSSH -> RSSH: Laboratory systems -> Quality management systems and accreditation Tuberculosis -> MDR-TB -> Case detection and diagnosis (MDR-TB) Tuberculosis -> MDR-TB -> Community MDR-TB care delivery Tuberculosis -> MDR-TB -> Treatment (MDR-TB) 5708999.74 10364556.38 16389978.49 1115831.46 481931.18 15279192.00 Global Fund commitment to KGZ-C-UNDPP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 15279192.00 Global Fund disbursement to KGZ-C-UNDPP03 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 50000.00 Global Fund commitment to KGZ-C-UNDPP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 3728604.00 Global Fund commitment to KGZ-C-UNDPP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 3481826.00 Global Fund disbursement to KGZ-C-UNDPP03 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 141476.00 Global Fund disbursement to KGZ-C-UNDPP03 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -50000.00 Global Fund commitment to KGZ-C-UNDPP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 100000.00 Global Fund commitment to KGZ-C-UNDPP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 50000.00 Global Fund disbursement to KGZ-C-UNDPP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 105302.00 Global Fund disbursement to KGZ-C-UNDPP03 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 1339773.09 Global Fund commitment to KGZ-C-UNDPP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 1339773.09 Global Fund disbursement to KGZ-C-UNDPP03 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 10761184.86 Global Fund commitment to KGZ-C-UNDPP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 414816.97 Global Fund disbursement to KGZ-C-UNDPP03 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 1145520.95 Global Fund disbursement to KGZ-C-UNDPP03 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 7505517.00 Global Fund disbursement to KGZ-C-UNDPP03 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 487033.94 Global Fund disbursement to KGZ-C-UNDPP03 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 58337.00 Global Fund disbursement to KGZ-C-UNDPP03 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 50000.00 Global Fund disbursement to KGZ-C-UNDPP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 1100074.00 Global Fund disbursement to KGZ-C-UNDPP03 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 49885.00 Global Fund disbursement to KGZ-C-UNDPP03 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 50000.00 Global Fund commitment to KGZ-C-UNDPP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 2121703.01 Global Fund commitment to KGZ-C-UNDPP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 464504.00 Global Fund disbursement to KGZ-C-UNDPP03 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 801440.01 Global Fund disbursement to KGZ-C-UNDPP03 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 49886.00 Global Fund disbursement to KGZ-C-UNDPP03 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 805873.00 Global Fund disbursement to KGZ-C-UNDPP03 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 50000.00 Global Fund disbursement to KGZ-C-UNDPP03 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -39690.23 Global Fund commitment to KGZ-C-UNDPP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 39690.23 Funds returned to the Global Fund from KGZ-C-UNDPP03 (Other 3rd Party). United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria -2699416.00 Global Fund commitment to KGZ-C-UNDPP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 2699416.00 Funds returned to the Global Fund from KGZ-C-UNDPP03 (Other 3rd Party). United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria 1676.95 Funds returned to the Global Fund from KGZ-C-UNDPP03 (Multilateral). United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria -1676.95 Global Fund commitment to KGZ-C-UNDPP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 141890.00 Funds returned to the Global Fund from KGZ-C-UNDPP03 (Other 3rd Party). United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria -141890.00 Global Fund commitment to KGZ-C-UNDPP03. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 5711732.51 Expenditure reported by United Nations Development Programme for KGZ-C-UNDPP03, Jan 2021 to Dec 2021. United Nations Development Programme 10366401.79 Expenditure reported by United Nations Development Programme for KGZ-C-UNDPP03, Jan 2022 to Dec 2022. United Nations Development Programme 13330059.50 Expenditure reported by United Nations Development Programme for KGZ-C-UNDPP03, Jan 2023 to Dec 2023. United Nations Development Programme 492817.44 Expenditure reported by United Nations Development Programme for KGZ-C-UNDPP03, Jan 2024 to Jun 2024. United Nations Development Programme 223495.61 Expenditure reported by United Nations Development Programme for KGZ-C-UNDPP03, Jul 2024 to Dec 2024. United Nations Development Programme 927293.14 Expenditure reported by United Nations Development Programme for KGZ-C-UNDPP03, Jan 2025 to Jun 2025. United Nations Development Programme 94324.27 Expenditure reported by United Nations Development Programme for KGZ-C-UNDPP03, Jul 2025 to Dec 2025. United Nations Development Programme <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>2020 - Funding Request - Window 1 - TB/HIV - Kyrgyzstan - English</narrative> Funding Request of funding request FR843-KGZ-C. <narrative>Number of people in prisons and other closed settings that have received an HIV test during the reporting period and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Number of people in prisons and other closed settings that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: National, 100% of national program target. Numerator: 4657; Denominator: 7079; Percentage: 65.79%. Numerator: 22. Numerator: 22. Numerator: 22. Numerator: 4635. Numerator: 4635. Numerator: 4635. Numerator: 5000; Denominator: 7079; Percentage: 70.63%. Numerator: 4422; Denominator: 6280; Percentage: 70.4%. Numerator: 4395; Denominator: 4422; Percentage: 99.39%. Numerator: 27; Denominator: 4422; Percentage: 0.61%. Numerator: 5000; Denominator: 7079; Percentage: 70.63%. Numerator: 4625; Denominator: 6193; Percentage: 74.7%. Numerator: 4592; Denominator: 4625; Percentage: 99.29%. Numerator: 33; Denominator: 4625; Percentage: 0.71%. Numerator: 5000; Denominator: 7079; Percentage: 70.63%. Numerator: 7159; Denominator: 6436; Percentage: 111.2%. Numerator: 7127; Denominator: 7159; Percentage: 99.55%. Numerator: 32; Denominator: 7159; Percentage: 0.45%. <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of men who have sex with men that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: National, 100% of national program target. Numerator: 7884; Denominator: 16900; Percentage: 46.65%. Numerator: 1922. Numerator: 1922. Numerator: 1922. Numerator: 5962. Numerator: 5962. Numerator: 5962. Numerator: 4. Numerator: 4. Numerator: 4. Numerator: 7880. Numerator: 7880. Numerator: 7880. Numerator: 10140; Denominator: 16900; Percentage: 60%. Numerator: 8999; Denominator: 16900; Percentage: 53.2%. Numerator: 7007. Numerator: 1992. Numerator: 8977. Numerator: 22. Numerator: 11000; Denominator: 16900; Percentage: 60%. Numerator: 10308; Denominator: 16900; Percentage: 61%. Numerator: 2739; Denominator: 10308; Percentage: 26.57%. Numerator: 7569; Denominator: 10308; Percentage: 73.43%. Numerator: 10291; Denominator: 10308; Percentage: 99.84%. Numerator: 17; Denominator: 10308; Percentage: 0.16%. Numerator: 12000; Denominator: 16900; Percentage: 71.01%. Numerator: 10492; Denominator: 16900; Percentage: 62.1%. Numerator: 8187; Denominator: 10492; Percentage: 78.03%. Numerator: 2305; Denominator: 10492; Percentage: 21.97%. Numerator: 10484; Denominator: 10492; Percentage: 99.92%. Numerator: 8; Denominator: 10492; Percentage: 0.08%. <narrative>Percentage of people newly diagnosed with HIV initiated on ART</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of people newly diagnosed with HIV initiated on ART</narrative> Geographic coverage: National, 100% of national program target. Numerator: 558; Denominator: 788. Numerator: 252; Denominator: 337. Numerator: 252; Denominator: 337. Numerator: 252; Denominator: 337. Numerator: 306; Denominator: 451. Numerator: 306; Denominator: 451. Numerator: 306; Denominator: 451. Numerator: 656; Denominator: 746. Numerator: 28; Denominator: 35. Numerator: 17; Denominator: 27. Numerator: 894; Denominator: 971. Numerator: 23; Denominator: 23. Numerator: 14; Denominator: 20. Numerator: 918; Denominator: 1031. Numerator: 24; Denominator: 919. Numerator: 21; Denominator: 919. <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: National, 100% of national program target. Numerator: 13491; Denominator: 25000; Percentage: 53.96%. Numerator: 261. Numerator: 261. Numerator: 261. Numerator: 14467. Numerator: 14467. Numerator: 14467. Numerator: 11. Numerator: 11. Numerator: 11. Numerator: 14717. Numerator: 14717. Numerator: 14717. Numerator: 12882. Numerator: 12882. Numerator: 12882. Numerator: 1846. Numerator: 1846. Numerator: 1846. Numerator: 13760; Denominator: 25000; Percentage: 55.04%. Numerator: 14070; Denominator: 25000; Percentage: 56.3%. Numerator: 13756. Numerator: 314. Numerator: 1911. Numerator: 12159. Numerator: 14067. Numerator: 3. Numerator: 15760; Denominator: 25000; Percentage: 63.04%. Numerator: 16102; Denominator: 25000; Percentage: 64.4%. Numerator: 15769; Denominator: 16102; Percentage: 97.93%. Numerator: 333; Denominator: 16102; Percentage: 2.07%. Numerator: 2328; Denominator: 16102; Percentage: 14.46%. Numerator: 13774; Denominator: 16102; Percentage: 85.54%. Numerator: 16093; Denominator: 16102; Percentage: 99.94%. Numerator: 9; Denominator: 16102; Percentage: 0.06%. Numerator: 17760; Denominator: 25000; Percentage: 71.04%. Numerator: 17692; Denominator: 25000; Percentage: 70.8%. Numerator: 17375; Denominator: 17692; Percentage: 98.21%. Numerator: 317; Denominator: 17692; Percentage: 1.79%. Numerator: 2724; Denominator: 17692; Percentage: 15.4%. Numerator: 14968; Denominator: 17692; Percentage: 84.6%. Numerator: 17682; Denominator: 17692; Percentage: 99.94%. Numerator: 10; Denominator: 17692; Percentage: 0.06%. <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of sex workers that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: National, 100% of national program target. Numerator: 3275; Denominator: 7103; Percentage: 46.11%. Numerator: 647. Numerator: 647. Numerator: 647. Numerator: 2628. Numerator: 2628. Numerator: 2628. Numerator: 9. Numerator: 9. Numerator: 9. Numerator: 3266. Numerator: 3266. Numerator: 3266. Numerator: 8. Numerator: 8. Numerator: 8. Numerator: 3267. Numerator: 3267. Numerator: 3267. Numerator: 4262; Denominator: 7103; Percentage: 60%. Numerator: 3225; Denominator: 7103; Percentage: 45.4%. Numerator: 2724. Numerator: 501. Numerator: 3187. Numerator: 15. Numerator: 3212. Numerator: 13. Numerator: 4500; Denominator: 7103; Percentage: 63.35%. Numerator: 3843; Denominator: 7103; Percentage: 54.1%. Numerator: 3304; Denominator: 3843; Percentage: 85.97%. Numerator: 539; Denominator: 3843; Percentage: 14.03%. Numerator: 3816; Denominator: 3843; Percentage: 99.3%. Numerator: 17; Denominator: 3843; Percentage: 0.44%. Numerator: 3832; Denominator: 3843; Percentage: 99.71%. Numerator: 11; Denominator: 3843; Percentage: 0.29%. Numerator: 5000; Denominator: 7103; Percentage: 70.39%. Numerator: 4670; Denominator: 7103; Percentage: 65.7%. Numerator: 3928; Denominator: 4670; Percentage: 84.11%. Numerator: 742; Denominator: 4670; Percentage: 15.89%. Numerator: 4670; Denominator: 4670; Percentage: 100%. Numerator: 0; Denominator: 4670; Percentage: 0%. Numerator: 4668; Denominator: 4670; Percentage: 99.96%. Numerator: 2; Denominator: 4670; Percentage: 0.04%. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Module: MDR-TB. <narrative>Number of TB cases with RR-TB and/or MDR-TB notified</narrative> Geographic coverage: National, 100% of national program target. Numerator: 48; Denominator: 1685; Percentage: 2.85%. Numerator: 48; Denominator: 1685; Percentage: 2.85%. Numerator: 48; Denominator: 1685; Percentage: 2.85%. Numerator: 1637; Denominator: 1685; Percentage: 97.15%. Numerator: 1637; Denominator: 1685; Percentage: 97.15%. Numerator: 1637; Denominator: 1685; Percentage: 97.15%. Numerator: 612; Denominator: 1685; Percentage: 36.32%. Numerator: 612; Denominator: 1685; Percentage: 36.32%. Numerator: 612; Denominator: 1685; Percentage: 36.32%. Numerator: 1073; Denominator: 1685; Percentage: 63.68%. Numerator: 1073; Denominator: 1685; Percentage: 63.68%. Numerator: 1073; Denominator: 1685; Percentage: 63.68%. Numerator: 1468. Numerator: 1697. Numerator: 914. Numerator: 896; Denominator: 914; Percentage: 98.03%. Numerator: 18; Denominator: 914; Percentage: 1.97%. Numerator: 365; Denominator: 914; Percentage: 39.93%. Numerator: 549; Denominator: 914; Percentage: 60.07%. Numerator: 1832. Numerator: 858. Numerator: 844; Denominator: 858; Percentage: 98.37%. Numerator: 14; Denominator: 858; Percentage: 1.63%. Percentage: 41.57%. Percentage: 58.43%. Numerator: 1850. Numerator: 768. Numerator: 782; Denominator: 836; Percentage: 93.54%. Numerator: 54; Denominator: 836; Percentage: 6.46%. Numerator: 328; Denominator: 836; Percentage: 39.23%. Numerator: 508; Denominator: 836; Percentage: 60.77%. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Module: MDR-TB. <narrative>Number of cases with RR-TB and/or MDR-TB that began second-line treatment</narrative> Geographic coverage: National, 100% of national program target. Numerator: 44; Denominator: 1382; Percentage: 3.18%. Numerator: 44; Denominator: 1382; Percentage: 3.18%. Numerator: 44; Denominator: 1382; Percentage: 3.18%. Numerator: 1338; Denominator: 1382; Percentage: 96.82%. Numerator: 1338; Denominator: 1382; Percentage: 96.82%. Numerator: 1338; Denominator: 1382; Percentage: 96.82%. Numerator: 721; Denominator: 1382; Percentage: 52.17%. Numerator: 721; Denominator: 1382; Percentage: 52.17%. Numerator: 721; Denominator: 1382; Percentage: 52.17%. Numerator: 174; Denominator: 1382; Percentage: 12.59%. Numerator: 174; Denominator: 1382; Percentage: 12.59%. Numerator: 174; Denominator: 1382; Percentage: 12.59%. Numerator: 517; Denominator: 1382; Percentage: 37.41%. Numerator: 517; Denominator: 1382; Percentage: 37.41%. Numerator: 517; Denominator: 1382; Percentage: 37.41%. Numerator: 865; Denominator: 1382; Percentage: 62.59%. Numerator: 865; Denominator: 1382; Percentage: 62.59%. Numerator: 865; Denominator: 1382; Percentage: 62.59%. Numerator: 1313. Numerator: 1612. Numerator: 934. Numerator: 43; Denominator: 934; Percentage: 4.6%. Numerator: 891; Denominator: 934; Percentage: 95.4%. Numerator: 377; Denominator: 934; Percentage: 40.36%. Numerator: 557; Denominator: 934; Percentage: 59.64%. Numerator: 755; Denominator: 934; Percentage: 80.84%. Numerator: 138; Denominator: 934; Percentage: 14.78%. Numerator: 1832. Numerator: 904. Numerator: 822; Denominator: 904; Percentage: 90.93%. Numerator: 82; Denominator: 904; Percentage: 9.07%. Numerator: 374; Denominator: 904; Percentage: 41.37%. Numerator: 530; Denominator: 904; Percentage: 58.63%. Numerator: 773; Denominator: 904; Percentage: 85.51%. Numerator: 164; Denominator: 904; Percentage: 18.14%. Numerator: 1850. Numerator: 776. Numerator: 726; Denominator: 776; Percentage: 93.56%. Numerator: 50; Denominator: 776; Percentage: 6.44%. Numerator: 308; Denominator: 776; Percentage: 39.69%. Numerator: 468; Denominator: 776; Percentage: 60.31%. Numerator: 590; Denominator: 776; Percentage: 76.03%. Numerator: 185; Denominator: 776; Percentage: 23.84%. <narrative>Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative> Module: MDR-TB. <narrative>Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) cases in the same year</narrative> Geographic coverage: National, 100% of national program target. Numerator: 3862; Denominator: 4008. Numerator: 2737; Denominator: 2910. Numerator: 2975; Denominator: 3129. Numerator: 3101; Denominator: 3262. <narrative>Percentage of confirmed RR/MDR-TB cases tested for resistance to second-line drugs</narrative> Module: MDR-TB. <narrative>Percentage of confirmed RR/MDR-TB cases tested for resistance to second-line drugs</narrative> Geographic coverage: National, 100% of national program target. Numerator: 992; Denominator: 1468. Numerator: 722; Denominator: 914. Numerator: 744; Denominator: 858. Numerator: 662; Denominator: 767. <narrative>Percentage of individuals receiving Opioid Substitution Therapy who received treatment for at least 6 months</narrative> Module: Prevention. <narrative>Percentage of individuals receiving Opioid Substitution Therapy who received treatment for at least 6 months</narrative> Geographic coverage: National, 100% of national program target. Numerator: 58; Denominator: 107. Numerator: 180; Denominator: 240. Numerator: 82; Denominator: 154. Numerator: 180; Denominator: 240. Numerator: 71; Denominator: 131. Numerator: 192; Denominator: 240. Numerator: 70; Denominator: 144. <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative> Module: Prevention. <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative> Geographic coverage: National, 100% of national program target. Numerator: 11147; Denominator: 16900; Percentage: 65.96%. Numerator: 2736. Numerator: 2736. Numerator: 2736. Numerator: 8411. Numerator: 8411. Numerator: 8411. Numerator: 12500; Denominator: 16900; Percentage: 73.96%. Numerator: 12581; Denominator: 16900; Percentage: 74.4%. Numerator: 9630. Numerator: 2951. Numerator: 13000; Denominator: 16900; Percentage: 76.92%. Numerator: 14464; Denominator: 16900; Percentage: 85.6%. Numerator: 10585; Denominator: 14464; Percentage: 73.18%. Numerator: 3879; Denominator: 14464; Percentage: 26.82%. Numerator: 13520; Denominator: 16900; Percentage: 80%. Numerator: 15830; Denominator: 16900; Percentage: 93.7%. Numerator: 11920; Denominator: 15830; Percentage: 75.3%. Numerator: 3910; Denominator: 15830; Percentage: 24.7%. <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative> Module: Prevention. <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative> Geographic coverage: National, 100% of national program target. Numerator: 17078; Denominator: 25000; Percentage: 68.31%. Numerator: 318. Numerator: 318. Numerator: 318. Numerator: 16760. Numerator: 16760. Numerator: 16760. Numerator: 2103. Numerator: 2103. Numerator: 2103. Numerator: 14975. Numerator: 14975. Numerator: 14975. Numerator: 17500; Denominator: 25000; Percentage: 70%. Numerator: 16973; Denominator: 25000; Percentage: 67.9%. Numerator: 16668. Numerator: 305. Numerator: 2186. Numerator: 0. Numerator: 18000; Denominator: 25000; Percentage: 72%. Numerator: 17379; Denominator: 25000; Percentage: 69.5%. Numerator: 17010; Denominator: 17379; Percentage: 97.88%. Numerator: 369; Denominator: 17379; Percentage: 2.12%. Numerator: 2539; Denominator: 17379; Percentage: 14.61%. Numerator: 20000; Denominator: 25000; Percentage: 80%. Numerator: 19831; Denominator: 25000; Percentage: 79.3%. Numerator: 19284; Denominator: 19831; Percentage: 97.24%. Numerator: 547; Denominator: 19831; Percentage: 2.76%. Numerator: 3273; Denominator: 19831; Percentage: 16.5%. Numerator: 0; Denominator: 19831; Percentage: 0%. <narrative>Percentage of sex workers reached with HIV prevention programs</narrative> Module: Prevention. <narrative>Percentage of sex workers reached with HIV prevention programs</narrative> Geographic coverage: National, 100% of national program target. Numerator: 4674; Denominator: 7103; Percentage: 65.8%. Numerator: 3841. Numerator: 3841. Numerator: 3841. Numerator: 833. Numerator: 833. Numerator: 833. Numerator: 4650. Numerator: 4650. Numerator: 4650. Numerator: 24. Numerator: 24. Numerator: 24. Numerator: 5000; Denominator: 7103; Percentage: 70.39%. Numerator: 4459; Denominator: 7103; Percentage: 62.8%. Numerator: 3659. Numerator: 800. Numerator: 4404. Numerator: 35. Numerator: 5500; Denominator: 7103; Percentage: 77.43%. Numerator: 4625; Denominator: 7103; Percentage: 65.1%. Numerator: 4014; Denominator: 4625; Percentage: 86.79%. Numerator: 611; Denominator: 4625; Percentage: 13.21%. Numerator: 4586; Denominator: 4625; Percentage: 99.16%. Numerator: 18; Denominator: 4625; Percentage: 0.39%. Numerator: 5700; Denominator: 7103; Percentage: 80.25%. Numerator: 5813; Denominator: 7103; Percentage: 81.8%. Numerator: 4929; Denominator: 5813; Percentage: 84.79%. Numerator: 884; Denominator: 5813; Percentage: 15.21%. Numerator: 5806; Denominator: 5813; Percentage: 99.88%. Numerator: 55; Denominator: 5813; Percentage: 0.95%. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Geographic coverage: National, 100% of national program target. Numerator: 121; Denominator: 130. Numerator: 139; Denominator: 146. Numerator: 139; Denominator: 144. Numerator: 114; Denominator: 115. <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative> Module: Treatment, care and support. <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative> Geographic coverage: National, 100% of national program target. Numerator: 4058; Denominator: 10000. Numerator: 7162; Denominator: 10000. Numerator: 4994; Denominator: 9200. Numerator: 8133; Denominator: 10000. Numerator: 5771; Denominator: 10688. Numerator: 9000; Denominator: 10000. Numerator: 6353; Denominator: 11000. 47045-KGZ-C-UNDP-4 The Global Fund to Fight AIDS, Tuberculosis and Malaria <narrative>Effective HIV and TB Control Project in the Kyrgyz Republic - Kyrgyzstan (01-Jan-2024-31-Dec-2026)</narrative> Kyrgyzstan, TB/HIV, United Nations Development Programme Goals: To minimize the impact of the HIV epidemic by reducing 30% of the incidence and mortality by 2027 compared to 2020, as a stage towards eliminating the epidemic in the Kyrgyz Republic by 2030; Success of treatment among drug resistant forms of MDR-TB by 2026, 80% according to NTP-6. Objectives: Ensure that 95% of people living with HIV (PLHIV) are aware of their HIV status; Cover 95% of people living with HIV with antiretroviral therapy (ART) and achieve viral load suppression in 95% of people receiving ART by 2026; To reduce the level of stigma and discrimination to less than 10% in government organizations providing HIV-related services to key populations and PLHIV; Ensure coordination and sustainable financing of HIV response measures by gradually increasing the share of government funding for HIV/ prevention and treatment programs to 80% by 2026; Ensure coordination and sustainable financing of TB response measures by gradually increasing the share of government funding for TB prevention and treatment programs to 50% by 2026; To ensure universal access to timely and quality diagnosis and treatment of M/XDR-TB. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme United Nations Development Programme The Global Fund to Fight AIDS, Tuberculosis and Malaria The Global Fund to Fight AIDS, Tuberculosis and Malaria Communications +41 58 791 1700 website@theglobalfund.org https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland The Global Fund to Fight AIDS, Tuberculosis and Malaria Grant Management Division xxxx xxxx Fund Portfolio Manager +41 58 791 1700 xxxx https://www.theglobalfund.org The Global Fund to Fight AIDS, Tuberculosis and Malaria, Global Health Campus, Chemin du Pommier 40, 1218 Grand-Saconnex, Geneva, Switzerland Kyrgyzstan HIV Tuberculosis Multicomponent, RSSH Ensure healthy lives and promote well-being for all at all ages End the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases, and combat hepatitis, water-borne diseases and other communicable diseases Achieve universal health coverage HIV -> Differentiated HIV Testing Services -> Facility-based testing for key population (KP) programs HIV -> Differentiated HIV Testing Services -> Self-testing for KP programs HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Condom and lubricant programming for MSM HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> HIV prevention communication, information and demand creation for MSM HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Pre-exposure prophylaxis (PrEP) programming for MSM HIV -> Prevention package for men who have sex with men (MSM) and their sexual partners -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for MSM HIV -> Prevention package for people in prisons and other closed settings -> Condom and lubricant programming for prisoners HIV -> Prevention package for people in prisons and other closed settings -> HIV prevention communication, information and demand creation for prisoners HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> Needle and syringe programs for PWID HIV -> Prevention package for people who use drugs (PUD) and their sexual partners -> Opioid substitution therapy and other medically assisted drug dependence treatment for PWID HIV -> Prevention package for sex workers, their clients and other sexual partners -> Condom and lubricant programming for sex workers HIV -> Prevention package for sex workers, their clients and other sexual partners -> Sexual and reproductive health services, including STIs, hepatitis, post-violence care for sex workers HIV -> Prevention package for transgender people and their sexual partners -> Condom and lubricant programming for transgender people HIV -> Prevention package for transgender people and their sexual partners -> HIV prevention communication, information and demand creation for transgender people HIV -> Reducing human rights-related barriers to HIV/TB services -> Eliminating stigma and discrimination in all settings HIV -> Reducing human rights-related barriers to HIV/TB services -> Ensuring rights-based law enforcement practices HIV -> Reducing human rights-related barriers to HIV/TB services -> Increasing access to justice (HIV/TB) HIV -> Treatment, care and support -> Diagnosis and management of advanced HIV disease (adults and children) HIV -> Treatment, care and support -> HIV treatment and differentiated service delivery - adults (15 and above) HIV -> Treatment, care and support -> HIV treatment and differentiated service delivery - children (under 15) HIV -> Treatment, care and support -> Treatment monitoring - Viral load and antiretroviral (ARV) toxicity Multicomponent -> Program management -> Grant management RSSH -> RSSH: Community systems strengthening -> Community-led research and advocacy RSSH -> RSSH: Health sector planning and governance for integrated people-centered services -> National health sector strategy, policy & regulations RSSH -> RSSH: Monitoring and evaluation systems -> Analyses, evaluations, reviews and data use RSSH -> RSSH: Monitoring and evaluation systems -> Operational Research Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB diagnosis/drug susceptibility testing (DST) Tuberculosis -> Drug-resistant (DR)-TB diagnosis, treatment and care -> DR-TB treatment, care and support Tuberculosis -> TB/HIV -> TB/HIV - Screening, testing and diagnosis 6929870.90 9081461.23 8551170.56 13361931.57 Global Fund commitment to KGZ-C-UNDPP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 8503788.91 Global Fund disbursement to KGZ-C-UNDPP04 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 2158726.66 Global Fund disbursement to KGZ-C-UNDPP04 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme -2699416.00 Global Fund commitment to KGZ-C-UNDPP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 4423179.00 Global Fund commitment to KGZ-C-UNDPP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 2699416.00 Global Fund commitment to KGZ-C-UNDPP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 2699416.00 Global Fund disbursement to KGZ-C-UNDPP04 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 4423179.00 Global Fund disbursement to KGZ-C-UNDPP04 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 3259528.00 Global Fund commitment to KGZ-C-UNDPP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 3259528.00 Global Fund disbursement to KGZ-C-UNDPP04 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 2978596.00 Global Fund commitment to KGZ-C-UNDPP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 2411228.43 Global Fund disbursement to KGZ-C-UNDPP04 (Multilateral). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 141890.00 Global Fund disbursement to KGZ-C-UNDPP04 (Other 3rd Party). The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 141890.00 Global Fund commitment to KGZ-C-UNDPP04. The Global Fund to Fight AIDS, Tuberculosis and Malaria United Nations Development Programme 6929870.89 Expenditure reported by United Nations Development Programme for KGZ-C-UNDPP04, Jan 2024 to Dec 2024. United Nations Development Programme 7250178.13 Expenditure reported by United Nations Development Programme for KGZ-C-UNDPP04, Jan 2025 to Dec 2025. United Nations Development Programme <narrative>Grant page on the data explorer of the Global Fund.</narrative> An overview of a grant over its lifetime. <narrative>Grant terms and conditions.</narrative> General terms and conditions which apply to Global Fund grants. <narrative>2023 - Funding Request - TB/HIV - Kyrgyzstan - English</narrative> Funding Request of funding request FR1405-KGZ-C. <narrative>Number of people in prisons and other closed settings that have received an HIV test during the reporting period and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Number of people in prisons and other closed settings that have received an HIV test during the reporting period and know their results</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. <narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of MSM that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 10308; Denominator: 16900. Numerator: 11830; Denominator: 16900. Numerator: 11448; Denominator: 16900. Numerator: 5324; Denominator: 16900. Numerator: 7934; Denominator: 16900. Numerator: 5915; Denominator: 16900. <narrative>Percentage of TG that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of TG that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 285. Numerator: 300. Numerator: 328. Numerator: 350. Numerator: 328; Denominator: 350; Percentage: 93.71%. Numerator: 400. <narrative>Percentage of people newly diagnosed with HIV initiated on ART</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of people newly diagnosed with HIV initiated on ART</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 894; Denominator: 971. Numerator: 919; Denominator: 973. Numerator: 989; Denominator: 1095. <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of people who inject drugs that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative> Geographic coverage: Subnational, 100% of national program target. Aggregation: Non cumulative. Numerator: 16102; Denominator: 25000. Numerator: 18750; Denominator: 25000. Numerator: 19121; Denominator: 25000. Numerator: 4500; Denominator: 25000. Numerator: 8326; Denominator: 25000. Numerator: 5000; Denominator: 25000. <narrative>Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative> Module: Differentiated HIV Testing Services. <narrative>Percentage of sex workers that have received an HIV test during the reporting period in KP-specific programs and know their results</narrative> Geographic coverage: Subnational, less than 100% national program target. Aggregation: Non cumulative. Numerator: 3843; Denominator: 9300. Numerator: 6975; Denominator: 9300. Numerator: 4459; Denominator: 9300. Numerator: 2511; Denominator: 9300. Numerator: 3119; Denominator: 9300. Numerator: 2790; Denominator: 9300. <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative> Module: Drug-resistant (DR)-TB diagnosis, treatment and care. <narrative>Number of people with confirmed RR-TB and/or MDR-TB notified</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. <narrative>Percentage of RR/MDR-TB patients with DST results for Fluoroquinolone among the total number of notified RR/MDR-TB patients during the reporting period</narrative> Module: Drug-resistant (DR)-TB diagnosis, treatment and care. <narrative>Percentage of RR/MDR-TB patients with DST results for Fluoroquinolone among the total number of notified RR/MDR-TB patients during the reporting period</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 684; Denominator: 837. Numerator: 626; Denominator: 729. Numerator: 580; Denominator: 655. <narrative>Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) patients during the reporting period</narrative> Module: Drug-resistant (DR)-TB diagnosis, treatment and care. <narrative>Percentage of TB patients with DST result for at least Rifampicin among the total number of notified (new and retreatment) patients during the reporting period</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 3013; Denominator: 3155. Numerator: 2902; Denominator: 3060. Numerator: 2921; Denominator: 3021. <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative> Module: Drug-resistant (DR)-TB diagnosis, treatment and care. <narrative>Percentage of people with confirmed RR-TB and/or MDR-TB that began second-line treatment</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 754; Denominator: 837. Numerator: 687; Denominator: 729. Numerator: 621; Denominator: 660. <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative> Module: Drug-resistant (DR)-TB diagnosis, treatment and care. <narrative>Treatment success rate of RR-TB and/or MDR-TB: Percentage of patients with RR and/or MDR-TB successfully treated</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 640; Denominator: 902. Numerator: 564; Denominator: 769. Numerator: 494; Denominator: 700. <narrative>Number of MSM who received any PrEP product at least once during the reporting period</narrative> Module: Prevention package for men who have sex with men (MSM) and their sexual partners. <narrative>Number of MSM who received any PrEP product at least once during the reporting period</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative> Module: Prevention package for men who have sex with men (MSM) and their sexual partners. <narrative>Percentage of men who have sex with men reached with HIV prevention programs</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 6111; Denominator: 16900. Numerator: 6760; Denominator: 16900. Numerator: 8134; Denominator: 16900. Numerator: 5324; Denominator: 16900. Numerator: 3902; Denominator: 16900. Numerator: 5915; Denominator: 16900. <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative> Module: Prevention package for people who use drugs (PUD) and their sexual partners. <narrative>Percentage of people who inject drugs reached with HIV prevention programs</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 14480; Denominator: 25000. Numerator: 15000; Denominator: 25000. Numerator: 15999; Denominator: 25000. Numerator: 6500; Denominator: 25000. Numerator: 5843; Denominator: 25000. Numerator: 7000; Denominator: 25000. <narrative>Percentage of people who inject drugs receiving opioid substitution therapy</narrative> Module: Prevention package for people who use drugs (PUD) and their sexual partners. <narrative>Percentage of people who inject drugs receiving opioid substitution therapy</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 791; Denominator: 25000. Numerator: 800; Denominator: 25000. Numerator: 837; Denominator: 25000. Numerator: 825; Denominator: 25000. Numerator: 785; Denominator: 25000. Numerator: 850; Denominator: 25000. <narrative>Percentage of sex workers reached with HIV prevention programs</narrative> Module: Prevention package for sex workers, their clients and other sexual partners. <narrative>Percentage of sex workers reached with HIV prevention programs</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 2017; Denominator: 9300. Numerator: 2325; Denominator: 9300. Numerator: 2005; Denominator: 9300. Numerator: 1674; Denominator: 9300. Numerator: 2109; Denominator: 9300. Numerator: 1953; Denominator: 9300. <narrative>Percentage of transgender people reached with HIV prevention programs - defined package of services</narrative> Module: Prevention package for transgender people and their sexual partners. <narrative>Percentage of transgender people reached with HIV prevention programs - defined package of services</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 188. Numerator: 200. Numerator: 311. Numerator: 220. Numerator: 129; Denominator: 220; Percentage: 58.64%. Numerator: 250. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Module: TB/HIV. <narrative>Percentage of HIV-positive new and relapse TB patients on ART during TB treatment</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative. Numerator: 139; Denominator: 144. Numerator: 113; Denominator: 115. Numerator: 79; Denominator: 80. <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative> Module: TB/HIV. <narrative>Percentage of people living with HIV currently enrolled on antiretroviral therapy who started TB preventive treatment (TPT) during the reporting period</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special. Numerator: 336; Denominator: 5771. Numerator: 943; Denominator: 6894. Numerator: 829; Denominator: 7507. <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative> Module: Treatment, care and support. <narrative>Percentage of people on ART among all people living with HIV at the end of the reporting period</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - other. Numerator: 5771; Denominator: 11000. Numerator: 8479; Denominator: 11737. Numerator: 6894; Denominator: 12000. Numerator: 9956; Denominator: 12291. Numerator: 7507; Denominator: 13000. Numerator: 11598; Denominator: 12851. <narrative>Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of vertical transmission of HIV</narrative> Module: Treatment, care and support. <narrative>Percentage of pregnant women living with HIV who received antiretroviral medicine to reduce the risk of vertical transmission of HIV</narrative> Geographic coverage: National, 100% of national program target. Aggregation: Non cumulative - special. Numerator: 147; Denominator: 186. Numerator: 175; Denominator: 190. Numerator: 134; Denominator: 145.